nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbimazole—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.0724	0.0766	CcSEcCtD
Carbimazole—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.0586	0.0621	CcSEcCtD
Carbimazole—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.0551	0.0583	CcSEcCtD
Carbimazole—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.0393	0.0416	CcSEcCtD
Carbimazole—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.0349	0.037	CcSEcCtD
Carbimazole—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.0344	0.0364	CcSEcCtD
Carbimazole—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.032	0.0339	CcSEcCtD
Carbimazole—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.032	0.0339	CcSEcCtD
Carbimazole—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.0306	0.0324	CcSEcCtD
Carbimazole—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.0296	0.0313	CcSEcCtD
Carbimazole—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0294	0.0312	CcSEcCtD
Carbimazole—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.0294	0.0312	CcSEcCtD
Carbimazole—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.0267	0.0283	CcSEcCtD
Carbimazole—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.026	0.0276	CcSEcCtD
Carbimazole—TPO—Differentiation Pathway—CNTF—amyotrophic lateral sclerosis	0.0239	0.43	CbGpPWpGaD
Carbimazole—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.0238	0.0252	CcSEcCtD
Carbimazole—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.0234	0.0248	CcSEcCtD
Carbimazole—Malaise—Riluzole—amyotrophic lateral sclerosis	0.0231	0.0245	CcSEcCtD
Carbimazole—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.0229	0.0243	CcSEcCtD
Carbimazole—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.0218	0.0231	CcSEcCtD
Carbimazole—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.0218	0.0231	CcSEcCtD
Carbimazole—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.0217	0.0229	CcSEcCtD
Carbimazole—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.0216	0.0228	CcSEcCtD
Carbimazole—Infection—Riluzole—amyotrophic lateral sclerosis	0.0208	0.022	CcSEcCtD
Carbimazole—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.0205	0.0217	CcSEcCtD
Carbimazole—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.0205	0.0217	CcSEcCtD
Carbimazole—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.0203	0.0215	CcSEcCtD
Carbimazole—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0191	0.0202	CcSEcCtD
Carbimazole—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.0172	0.0183	CcSEcCtD
Carbimazole—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.0166	0.0176	CcSEcCtD
Carbimazole—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.0165	0.0175	CcSEcCtD
Carbimazole—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.0154	0.0163	CcSEcCtD
Carbimazole—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.0148	0.0157	CcSEcCtD
Carbimazole—Rash—Riluzole—amyotrophic lateral sclerosis	0.0132	0.014	CcSEcCtD
Carbimazole—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.0132	0.014	CcSEcCtD
Carbimazole—Headache—Riluzole—amyotrophic lateral sclerosis	0.0131	0.0139	CcSEcCtD
Carbimazole—Nausea—Riluzole—amyotrophic lateral sclerosis	0.0124	0.0132	CcSEcCtD
Carbimazole—TPO—Amino acid and derivative metabolism—DAO—amyotrophic lateral sclerosis	0.0044	0.079	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—GRN—amyotrophic lateral sclerosis	0.00291	0.0524	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—IGF1—amyotrophic lateral sclerosis	0.00253	0.0454	CbGpPWpGaD
Carbimazole—CYP19A1—FSH signaling pathway—BDNF—amyotrophic lateral sclerosis	0.00188	0.0338	CbGpPWpGaD
Carbimazole—TPO—Differentiation Pathway—VEGFA—amyotrophic lateral sclerosis	0.00165	0.0297	CbGpPWpGaD
Carbimazole—TPO—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00112	0.0201	CbGpPWpGaD
Carbimazole—TPO—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00112	0.0201	CbGpPWpGaD
Carbimazole—TPO—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00102	0.0184	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000992	0.0178	CbGpPWpGaD
Carbimazole—TPO—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000949	0.0171	CbGpPWpGaD
Carbimazole—TPO—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000893	0.016	CbGpPWpGaD
Carbimazole—TPO—Metabolism—DAO—amyotrophic lateral sclerosis	0.000807	0.0145	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000764	0.0137	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000699	0.0126	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00065	0.0117	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000612	0.011	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000611	0.011	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—ATF1—amyotrophic lateral sclerosis	0.000591	0.0106	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSR—amyotrophic lateral sclerosis	0.000565	0.0102	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000563	0.0101	CbGpPWpGaD
Carbimazole—TPO—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000464	0.00834	CbGpPWpGaD
Carbimazole—CYP19A1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000444	0.00798	CbGpPWpGaD
Carbimazole—CYP19A1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000438	0.00787	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000419	0.00753	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00034	0.00612	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00034	0.00612	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000317	0.0057	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000311	0.0056	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000289	0.0052	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000272	0.00489	CbGpPWpGaD
Carbimazole—TPO—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000249	0.00448	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000246	0.00442	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000237	0.00426	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000229	0.00412	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000201	0.00362	CbGpPWpGaD
Carbimazole—TPO—Metabolism—APOE—amyotrophic lateral sclerosis	0.000188	0.00339	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000186	0.00335	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000172	0.00309	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000157	0.00282	CbGpPWpGaD
Carbimazole—CYP19A1—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000152	0.00273	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000141	0.00254	CbGpPWpGaD
Carbimazole—TPO—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000129	0.00232	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000129	0.00232	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	8.83e-05	0.00159	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.59e-05	0.00137	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.98e-05	0.00125	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—APOE—amyotrophic lateral sclerosis	5.74e-05	0.00103	CbGpPWpGaD
Carbimazole—CYP19A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.93e-05	0.000707	CbGpPWpGaD
